Revises telehealth and telemedicine requirements concerning adult prescription of certain Schedule II drugs for treatment of attention-deficit/hyperactivity disorder.
2026/09/24 Introduced, Referred to Assembly Health Committee
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | NJ A5364 | 0 | 13.78 | 10-09-2026 |
| 2 | NJ A5539 | 0 | 19.41 | 24-09-2026 |
| 3 | NJ A5530 | 0 | 12.14 | 17-09-2026 |
| 4 | NJ A5538 | 0 | 17.78 | 24-09-2026 |
| 5 | NJ A5500 | 0 | 9.76 | 14-09-2026 |
| 6 | NJ A4957 | 0 | 17.69 | 07-05-2026 |
| 7 | NJ A5464 | 0 | 12.49 | 14-09-2026 |
| 8 | NJ A5505 | 0 | 14 | 17-09-2026 |
| 9 | NJ A4694 | 0 | 13.7 | 16-03-2026 |
| 10 | NJ A5231 | 0 | 13.78 | 08-06-2026 |